Control of invasive meningococcal disease: is it achievable?
Neisseria meningitidis still leads to deaths and severe disability in children, adolescents and adults. Six different capsular groups of N. meningitidis cause invasive meningococcal disease in the form of meningitis and septicaemia in humans. Although conjugate meningococcal vaccines have been devel...
Main Authors: | Marshall, H, Wang, B, Wesselingh, S, Snape, M, Pollard, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Lippincott, Williams and Wilkins
2016
|
Similar Items
-
Meningococcal polysaccharide-protein conjugate vaccines.
by: Snape, MD, et al.
Published: (2005) -
Meningococcal disease
by: Pollard, A
Published: (2018) -
Erratum: Meningococcal polysaccharide-protein conjugate vaccines (Lancet Infective Diseases (2005) 5 (21-30)
by: Snape, MD, et al.
Published: (2005) -
Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease.
by: Pollard, A, et al.
Published: (2013) -
Meningococcal polysaccharide-protein conjugate vaccines (vol 5, pg 21, 2005)
by: Snape, MD, et al.
Published: (2005)